Literature DB >> 21918739

Two pathogenic mutations located within the 5'-regulatory sequence of the GJB1 gene affecting initiation of transcription and translation.

Dagmara Kabzińska1, Katarzyna Kotruchow, Barbara Ryniewicz, Andrzej Kochański.   

Abstract

In contrast to mutations in the coding sequences of a genes involved in the pathogenesis of Charcot-Marie-Tooth disease (CMT), little is known about CMT phenotypes resulting from a DNA variants located in regulatory sequences of a given " CMT gene". Charcot-Marie-Tooth type X1 disease (CMTX1) is caused by mutations in the GJB1 gene coding for an ion channel known as connexin, with a molecular mass of 32 kDa (Cx32). Only 0.01% of the GJB1 gene mutations have been reported in its 5' regulatory sequence. Pathogenic mutations occured in the internal ribosome entry site (IRES) are extremely rarely reported in human genetic disorders. To the best of our knowledge, in this study we report for the first time in an Eastern European population, two CMTX1 families in which two pathogenic mutations in the 5' regulatory sequence of the GJB1 gene (c.-529T>C and -459C>T) have been found. The two mutations identified in our study disturb the 5' UTR sequence in two different ways, by affecting the transcription factor SOX10 binding site (c.-529T>C) and by the disrupting IRES element of GJB1 gene (c.-459C>T). These regions are responsible for transcription (SOX10) and initiation of translation (IRES), respectively. On the basis of our findings that, in contrast to the most DNA sequence variants reported in untranslated regulatory regions of genes, the c.-459C>T and c.-529T>C mutations remain pathogenic in the context of different ethnic background.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21918739

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  4 in total

1.  Secondary RNA structure and nucleotide specificity contribute to internal initiation mediated by the human tau 5' leader.

Authors:  Bethany L Veo; Leslie A Krushel
Journal:  RNA Biol       Date:  2012-09-20       Impact factor: 4.652

2.  Establishing and validating regulatory regions for variant annotation and expression analysis.

Authors:  Alexander Kaplun; Mathias Krull; Karthick Lakshman; Volker Matys; Birgit Lewicki; Jennifer D Hogan
Journal:  BMC Genomics       Date:  2016-06-23       Impact factor: 3.969

3.  Mutations in noncoding regions of GJB1 are a major cause of X-linked CMT.

Authors:  Pedro J Tomaselli; Alexander M Rossor; Alejandro Horga; Zane Jaunmuktane; Aisling Carr; Paola Saveri; Giuseppe Piscosquito; Davide Pareyson; Matilde Laura; Julian C Blake; Roy Poh; James Polke; Henry Houlden; Mary M Reilly
Journal:  Neurology       Date:  2017-03-10       Impact factor: 9.910

4.  Revisiting the pathogenic mechanism of the GJB1 5' UTR c.-103C > T mutation causing CMTX1.

Authors:  Bianca R Grosz; John Svaren; Gonzalo Perez-Siles; Garth A Nicholson; Marina L Kennerson
Journal:  Neurogenetics       Date:  2021-06-05       Impact factor: 2.660

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.